There were 353 press releases posted in the last 24 hours and 431,660 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image